Secondary
Rigel Pharmaceuticals
We are a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematological disorders, cancer and rare diseases.
Symbol
RIGL
Final Price
$3.88
Anticipated Date
TBD
Underwriters
Jefferies, Piper Jaffray, BMO Capital Markets, H.C. Wainwright & Co.
To view the prospectus for Rigel Pharmaceuticals, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277